Individual research interview
You are invited to participate in an individual interview 90 to 120 minutes long, conducted by a member of our research team. Confidentiality is guaranteed. Monetary compensation offered!
Topics explored during the individual research interview:
Health and well-being
Importance of music in your life
Consumption of alcohol and other drugs
Services and treatments received
Gender identity and sexual orientation
Sexuality
Experience with violence
Future outlook
To participate, you must:
be 18 or over;
use alcohol or drugs on a regular basis; and
have health, housing, employment, legal, money or other problems.
What must I do to participate?
Contact us by telephone, email or Facebook to find out more about the project.
Advisory Committee
An advisory committee has been created to direct the principal stages of the research and to help develop the guidelines.
Who sits on the committee?
Where, when and how often does the committee meet?
How can I get involved?
Different stakeholders, including community and professional associations with experiential or professional knowledge of addiction or gender identity issues.
Members attend two or three meetings per year (2019-2022), each three hours long, either in person or by videoconference. The gatherings are friendly, lively affairs where everyone is encouraged to express their point of view on the stages of the research.
If you are interested in joining the Advisory Committee – Belgium – for the Gender-ARP project, contact us by telephone or email to find out more about how to go about it.
Consensus developement process
Drawing on the results of the research, a consensus development process will be used to bring together a group of experiential and professional experts situated in Quebec (Canada), Belgium and France. These experts will take part in a process of exchange and deliberation aimed at reaching a consensus on the guidelines that should be applied regarding long-term, integrated, gender-sensitive services offered to people who use alcohol or drugs.